US govt criticizes Indonesia over H5N1 samples

27 April 2008

The US Secretary of Health and Human Services, Michael Leavitt, has criticized Indonesia's government for its refusal to share avian influenza samples. The US official's position mirrors that of the World Health Organization (Marketletters passim). However, the fact that most of the world's major drug companies are headquartered in the USA and, according to Indonesia's Health Minister, Siti Fadilah Supari, have most to gain commercially from the development of a vaccine against a pandemic flu outbreak, makes it likely that the call will not be well received.

Mr Leavitt told the Associated Press, while on a tour of Indonesia, Singapore and Vietnam, that "if Indonesia decides not to be a part of the world community and the international mainstream on this for a time, that would be regrettable."

In March, the US Embassy in Jakarta, Indonesia, was forced to deny conspiracy theories circulating in the capital that H5N1 samples were being collected by the US military for the development of biological weapons (Marketletter March 24).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight